subject: Stock Updates From Pennytobuck On Cypb, Wdfc, And Tgmp [print this page] American Power Corporation (OTCBB:TGMP) recently announced that it will proceed to kick start the development of its advanced Pace Coal Project in Judith Basin County, Montana.
In April 2010, TGMP acquired roughly 29,000 acres, which make up the Pace Coal Project. In 1979 Mobil Oil Co. (now ExxonMobil) drilled 30 holes over 14,000 of the projects acreage, and delivered 45 samples which were later sent to an independent laboratory for analysis. It was subsequently determined that both the quality and the quantity of coal on the Pace acreage was high and significant, respectively.
TGMP has access to a large and experienced workforce in Great Falls, Montana, and the coal project may provide hundreds, if not thousands, of new, high-paying jobs for the local economy (according to the U.S. Bureau of Labor Statistics, the average annual wage in the mining industry in Montana was $70,779 in 2008, or 122 percent higher than the average wage in the state).
To get more information on TGMP visit them at http://americanpowerco.com
WD-40 Company (Nasdaq:WDFC) reported it's fiscal 2010 diluted earnings per share is expected to meet or exceed the top end of its guidance previously issued on July 7, 2010.
WDFC previously announced guidance for fiscal year 2010 net sales of $313.0 million to $319.0 million or growth between 7.2% and 9.2% versus fiscal year 2009. WDFC previously announced it expects net income of $34.4 million to $36.0 million and diluted earnings per share of $2.05 to $2.14 for fiscal year 2010 based on an estimated 16.8 million weighted average shares outstanding. The company also previously announced it expects advertising and sales promotion expenses to be within the range of 6.5% to 7.5% of net sales.
WD-40 Company markets its products in more than 160 countries worldwide and recorded sales of $292 million in fiscal year 2009. Additional information about WD-40 Company can be obtained online at http://www.wd40company.com.
Cypress Bioscience, Inc. (NASDAQ:CYPB) announced that it has licensed Alexza Pharmaceutical's (NASDAQ:ALXA) Staccato nicotine technology -- a novel electronic multidose delivery technology designed to help people stop smoking. The innovative Staccato nicotine technology is intended to improve on a well-validated smoking cessation approach by delivering nicotine via inhalation, thus mimicking the actual nicotine effects of smoking without the deleterious side effects associated with cigarettes.
About Smoking
Despite decades of public health and medical intervention, smoking remains one of the most preventable causes of death in the United States(1). Smoking continues to exact a staggering toll on human health, claiming more than 430,000 lives annually in the U.S.(2,3) One in five deaths in the U.S. are attributable to smoking related illness(2,4). While the vast majority of smokers indicate an interest in quitting(5), approximately 80% of smokers who try to quit on their own relapse in one month, and only 3% will remain abstinent at six months(6). Current nicotine replacement therapies (nasal, buccal and transdermal), nicotinic agonists, and other prescription therapies approximately double the rates of abstinence as compared to placebo, but even so the vast majority of smokers using these treatments relapse within six months(7). The scientific community has called for the development of a pulmonary nicotine delivery system that more closely mimics the blood levels of nicotine produced through smoking, as such a system could be differentially effective in helping smokers to quit(7,8,9).
About Staccato Nicotine
Staccato nicotine is designed to help smokers quit by addressing both the chemical and behavioral components of nicotine addiction by combining nicotine replacement via inhalation with a user-friendly drug delivery device. The Staccato technology may be capable of mimicking the pharmacokinetics of smoking cigarettes through the delivery of optimally-sized nicotine particles to the deep lung. Staccato nicotine may also provide some of the psychological aspects of smoking (e.g., hand-to-mouth movement, oral inhalation) and could allow smokers to self-administer and possibly titrate to the dose to treat cravings. Importantly, the electronics embedded within the Staccato delivery system could allow for the programmed, over-time reduction in the overall daily dose of nicotine, and ultimately may lead to the better management of nicotine cravings and eventual sustained smoking cessation.
To get more information on CYPB visit them at http://www.cypressbio.com
For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations.The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty-five thousand dollars in cash from a third party (Winning Media) for (3) days of advertising for Gold American Mining Corp (SILA.OB)
